TMEM109 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.073800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.319570E-01
Normal-vs-Stage2
5.378800E-01
Normal-vs-Stage3
2.334600E-01
Normal-vs-Stage4
8.823000E-01
Stage1-vs-Stage2
6.123200E-01
Stage1-vs-Stage3
5.405200E-01
Stage1-vs-Stage4
5.015200E-01
Stage2-vs-Stage3
2.911800E-01
Stage2-vs-Stage4
6.578800E-01
Stage3-vs-Stage4
4.245200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.001800E-01
Normal-vs-AfricanAmerican
3.825200E-01
Normal-vs-Asian
5.941200E-01
Caucasian-vs-AfricanAmerican
9.666000E-01
Caucasian-vs-Asian
9.905200E-01
AfricanAmerican-vs-Asian
9.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.931800E-01
Normal-vs-Female
5.290800E-01
Male-vs-Female
5.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.008500E-02
Normal-vs-Age(41-60Yrs)
9.250000E-01
Normal-vs-Age(61-80Yrs)
3.993400E-01
Normal-vs-Age(81-100Yrs)
2.122400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.953760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.237600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.726800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.390400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.238500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.153000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.272000E-01
Normal-vs-Daily Drinker
6.398200E-01
Normal-vs-Weekly Drinker
7.034800E-01
Normal-vs-Occasional Drinker
6.477600E-01
Normal-vs-Social Drinker
4.014000E-01
Non Drinker-vs-Daily Drinker
3.252800E-01
Non Drinker-vs-Weekly Drinker
5.167600E-01
Non Drinker-vs-Occasional Drinker
1.685820E-01
Non Drinker-vs-Social Drinker
7.470200E-01
Daily Drinker-vs-Weekly Drinker
9.084400E-01
Daily Drinker-vs-Occasional Drinker
7.748800E-01
Daily Drinker-vs-Social Drinker
5.315600E-01
Weekly Drinker-vs-Occasional Drinker
7.617800E-01
Weekly Drinker-vs-Social Drinker
7.206600E-01
Occasional Drinker-vs-Social Drinker
3.290000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.110600E-01
Normal-vs-Grade 2
7.609800E-01
Normal-vs-Grade 3
8.029000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.343000E-03
Grade 1-vs-Grade 3
7.454200E-02
Grade 1-vs-Grade 4
9.110600E-01
Grade 2-vs-Grade 3
3.171800E-01
Grade 2-vs-Grade 4
7.609800E-01
Grade 3-vs-Grade 4
8.029000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.552800E-01
Normal-vs-NonDiabetic
4.686200E-01
Diabetic-vs-NonDiabetic
6.560200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.704400E-01
Normal-vs-NoPancreatitis
4.888600E-01
Pancreatitis-vs-NoPancreatitis
4.296500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.760800E-01
Normal-vs-N1
5.615800E-01
N0-vs-N1
5.170200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.719600E-02
Normal-vs-TP53-NonMutant
6.736400E-03
TP53-Mutant-vs-TP53-NonMutant
2.260200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
